Skin Analytics launches DERM Zero at HLTH Europe 2026
The AI-powered solution uses Class III medical device technology to deliver clinical-grade skin cancer assessments from a standard smartphone.
See the latest news and media coverage for Skin Analytics. We track all announcements, press releases, and industry mentions in real time, all in one place.
AI dermatology triage and teledermatology platform
skin-analytics.comLast updated
In short: Skin Analytics launched DERM Zero, the world's first Class III medical device technology for autonomous skin cancer assessment via smartphone.
The AI-powered solution uses Class III medical device technology to deliver clinical-grade skin cancer assessments from a standard smartphone.
First West Yorkshire trust launches AI platform for instant lesion analysis in tele-dermatology service, triaging patients efficiently. Three-year programme includes independent evaluation.
DERM, a Class III CE-marked AI for skin cancer, outperforms dermatologists in NPV (99.8%), saves costs, and reduces appointments. Used by 25 NHS partners; NICE conditionally recommends it.
Bupa offers AI skin cancer checks via DERM-powered at-home kits. The AI achieves 99.9% accuracy in ruling out melanoma.
Extensive hospital testing has paved the way for a new digital solution that can detect cancer from home.
The world's first regulated medical device technology approved to autonomously assess skin cancer from a smartphone will be unveiled today at HLTH Europe.
Bradford Teaching Hospitals NHS Foundation Trust has begun using AI with the aim of detecting skin cancer earlier.
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues...
Track Skin Analytics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.